Bioxyne Limited (ASX:BXN) Signs Exclusive $7M Agreement with NectarTek
Bioxyne Limited (ASX:BXN) secures a $7 million manufacturing agreement with NectarTek, significantly increasing FY2026 revenue projections.
Category: ASX-BXN
BIOXYNE LIMITED
Latest News
Dropsuite Limited (ASX:DSE) Declared Unacceptable Circumstances
Bigtincan Holdings Limited (ASX:BTH) Shareholders Approve Acquisition Scheme
Structural Monitoring Systems PLC (ASX:SMN) Updates on US Tariffs Impact
Russell Investments Australian Government Bond ETF (ASX:RGB) Announces Final Distribution
Ansell Limited (ASX:ANN) Announces US Tariffs Update
Mesoblast (ASX:MSB) Announces U.S. Tariff Exemption for Allogeneic Cell Therapies
Orthocell Limited (ASX:OCC) Receives FDA Clearance for Remplir™
US Masters Residential Property Fund (ASX:URF) Announces On-Market Buy-Back
WT Financial Group Limited (ASX:WTL) Announces First Hubco Formation Plans
Australian Rare Earths Limited (ASX:AR3) Confirms Uranium Intersections
The Hub of Australian Finance News